Published By: Zion Research

Vaccine Market by Technology (Inactivated, Subunit, Conjugate, Live

Attenuated, Toxoid, and Dendritic Cell Synthetic), Type (Therapeutic,
Preventive), Indication (Allergy, Infectious Disease, Tumors and Others)
for Infants, Early Aged, and Post Aged: Global Industry Perspective,
Comprehensive Analysis, Size, Share, Growth, Segment, Trends and
Forecast, 2014 2020

Joel John
3422 SW 15 Street, Suit #8138,
Deerfield Beach,
Florida 33442, USA
Tel: +1-386-310-3803
Toll Free: 1-855-465-4651
www.marketresearchstore.com
sales@marketresearchstore.com

Vaccine Market

The report covers forecast and analysis for the Vaccine Market on a global and regional level. The
study provides historic data of 2014 along with a forecast from 2015 to 2020 based revenue (USD
Million). The study includes drivers and restraints for the market along with the impact they have on
the demand over the forecast period. Additionally, the report includes study of opportunities available
in the vaccine market on a global level.
In order to give the users of this report a comprehensive view on the vaccine market, we have
included a detailed competitive scenario, and product portfolio of key vendors. To understand the
competitive landscape in the market, an analysis of Porters five forces model for the vaccine market
has also been included. The study encompasses a market attractiveness analysis, wherein technology
segments are benchmarked based on their market size, growth rate and general attractiveness.
Browse the full "Vaccine Market by Technology (Inactivated, Subunit, Conjugate, Live Attenuated,
Toxoid, and Dendritic Cell Synthetic), Type (Therapeutic, Preventive), Indication (Allergy, Infectious
Disease, Tumors and Others) for Infants, Early Aged, and Post Aged: Global Industry Perspective,
Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2014 2020" report
at http://www.marketresearchstore.com/report/vaccine-market-z53045

The study provides a decisive view on the vaccine market by segmenting the market based on
technology, type, end-users, indication and region. Inactivated, subunit, conjugate, live attenuated,
toxoid, dendritic cell and synthetic are the technological segments of the vaccine market. Preventive
and therapeutic are the two types of vaccine. All the segments have been analyzed based on present
and future trends and the market is estimated from 2014 to 2020. The regional segmentation includes
sales@marketresearchstore.com

Vaccine Market
the current and forecast demand for North America, Europe, Asia Pacific, Latin America and Middle
East and Africa with its further bifurcation into major countries including U.S. Germany, France, UK,
China, Japan, India and Brazil.
The report covers detailed competitive outlook including company profiles of the key participants
operating in the global market. Key players profiled in the report include Pfizer, CSL Limited,
GlaxoSmithKline, plc, MedImmune, LLC, Novartis AG, Sanofi Pasteur, Merck and Company,
Johnson and Johnson and Emergent BioSolutions Inc among others.
Get Request Sample at http://goo.gl/wygeI6
This report segments the vaccine market as follows:
Vaccine Market: Technology Segment Analysis

Inactivated
Subunit
Conjugate
Live Attenuated
Toxoid
Dendritic Cell
Synthetic

Vaccine Market: Type Segment Analysis

sales@marketresearchstore.com

Vaccine Market

Therapeutic vaccine
Preventive vaccine

Vaccine Market: End user Segment Analysis

Infants
Early aged
Post aged

Vaccine Market: Indications Segment Analysis

Allergy
Infectious disease
Tumors
Others

Vaccine Market: Regional Segment Analysis

North America
o US
Europe
o Germany
o France
o UK
Asia Pacific
o China
sales@marketresearchstore.com

Vaccine Market
o
o

Japan
India
Latin America
o Brazil
Middle East and Africa

Get Illustrative Sample before buying: http://goo.gl/N5fhYL

Chapter 1. Introduction
1.1. Report description and scope
1.2. Research scope
1.3. Research methodology
1.3.1. Market research process
1.3.2. Market research methodology
Chapter 2. Executive Summary
2.1. Global market revenue, 2014 - 2020(USD Million)
2.2. Global vaccine market: Snapshot
sales@marketresearchstore.com

Vaccine Market
Chapter 3. Vaccine Market Global and Industry Analysis
3.1. Vaccine : Market dynamics
3.2. Market drivers
3.2.1. Drivers of global vaccine market: Impact analysis
3.2.2. Rise in frequency of diseases worldwide
3.2.3. Introduction of new vaccines
3.3. Market restraints
3.3.1. Restraints of global vaccine market: Impact analysis
3.3.2. High maintenance for preservation of vaccines
3.3.3. Strict laws of regulatory for production of vaccine
3.3.4. Huge expense for R&D of vaccines
3.4. Opportunities
3.4.1. Increasing demand from developing countries
3.4.2. Government initiatives
3.4.3. Development of new vaccines
3.5. Porters five forces analysis
3.6. Market Attractiveness Analysis
sales@marketresearchstore.com

Vaccine Market
3.6.1. Market attractiveness analysis by technology segment
3.6.2. Market attractiveness analysis by type segment
3.6.3. Market attractiveness analysis by end user segment
3.6.4. Market attractiveness analysis by indication segment
3.6.5. Market attractiveness analysis by regional segment
Chapter 4. Global Vaccine Market - Competitive Landscape
4.1. Company market share, 2014
4.2. Price trend analysis
Chapter 5. Global Vaccine Market Technology Segment Analysis
5.1. Global vaccine market: technology overview
5.1.1. Global vaccine market revenue share, by technology, 2014 - 2020
5.2. Inactivated vaccines
5.2.1. Global inactivated vaccines market, by technology, 2014 2020 (USD
Million)
5.3. Subunit vaccines
5.3.1. Global subunit vaccines market, by technology, 2014 2020 (USD Million)
5.4. Conjugate vaccines
sales@marketresearchstore.com

Vaccine Market
5.4.1. Global conjugate vaccines market, by technology, 2014 2020 (USD
Million)
5.5. Live attenuated vaccines
5.5.1. Global live attenuated vaccines market, by technology, 2014 2020 (USD
Million)
5.6. Toxoid vaccines
5.6.1. Global toxoid vaccines market, by technology, 2014 2020 (USD Million)
5.7. Others (dendritic cell vaccines, synthetic vaccines)
5.7.1. Global others vaccines market, by technology, 2014 2020 (USD Million)
Chapter 6. Global Vaccine Market Type Segment Analysis
6.1. Global vaccine market: type overview
6.1.1. Global vaccine market revenue share, by type, 2014 - 2020
6.2. Therapeutic vaccines
6.2.1. Global therapeutic vaccines market, by type, 2014 2020 (USD Million)
6.3. Preventive vaccines
6.3.1. Global preventive vaccines market, by type, 2014 2020 (USD Million)
Chapter 7. Global Vaccine Market End users Segment Analysis
sales@marketresearchstore.com

Vaccine Market
7.1. Global vaccine market: type overview
7.1.1. Global vaccine market revenue share, by end users, 2014 - 2020
7.2. Infants
7.2.1. Global infants market, by type, 2014 2020 (USD Million)
7.3. Early aged
7.3.1. Global early aged market, by end users, 2014 2020 (USD Million)
7.4. Post aged
7.4.1. Global post aged market, by end users, 2014 2020 (USD Million)
Chapter 8. Global Vaccine Market Indication Segment Analysis
8.1. Global vaccine market: type overview
8.1.1. Global vaccine market revenue share, by indication, 2014 - 2020
8.2. Allergy
8.2.1. Global allergy market, by indication, 2014 2020 (USD Million)
8.3. Infectious disease
8.3.1. Global infectious disease market, by indication, 2014 2020 (USD Million)
8.4. Others
8.4.1. Global others market, by indication, 2014 2020 (USD Million)
sales@marketresearchstore.com

Vaccine Market
Chapter 9. Global Vaccine market Regional Segment Analysis
9.1. Global vaccine market: Regional overview
9.1.1. Global vaccine market revenue share by region, 2014 - 2020
9.2. North America
9.2.1. North America vaccine market revenue, by technology, 2014 2020 (USD
Million)
9.2.2. North America vaccine market revenue, by type, 2014 2020 (USD
Million)
9.2.3. North America vaccine market revenue, by end user, 2014 2020 (USD
Million)
9.2.4. U.S.
9.2.4.1. U.S. vaccine market revenue, by technology, 2014 2020 (USD
Million)
9.2.4.2. U.S. vaccine market revenue, by type, 2014 2020 (USD Million)
9.2.4.3. U.S. vaccine market revenue, by end user, 2014 2020 (USD
Million)
9.3. Europe
sales@marketresearchstore.com

Vaccine Market
9.3.1. Europe vaccine market revenue, by a technology, 2014 2020 (USD
Million)
9.3.2. Europe vaccine market revenue, by type, 2014 2020 (USD Million)
9.3.3. Europe vaccine market revenue, by end user, 2014 2020 (USD Million)
9.3.4. Germany
9.3.4.1. Germany vaccine market revenue, by technology, 2014 2020
(USD Million)
9.3.4.2. Germany vaccine market revenue, by type, 2014 2020 (USD
Million)
9.3.4.3. Germany vaccine market revenue, by end user, 2014 2020 (USD
Million)
9.3.5. France
9.3.5.1. France vaccine market revenue, by technology, 2014 2020 (USD
Million)
9.3.5.2. France vaccine market revenue, by type, 2014 2020 (USD
Million)

sales@marketresearchstore.com

Vaccine Market
9.3.5.3. France vaccine market revenue, by end user, 2014 2020 (USD
Million)
9.3.6. UK
9.3.6.1. UK vaccine market revenue, by technology, 2014 2020 (USD
Million)
9.3.6.2. UK vaccine market revenue, by type, 2014 2020 (USD Million)
9.3.6.3. UK vaccine market revenue, by end user, 2014 2020 (USD
Million)
9.4. Asia Pacific
9.4.1. Asia Pacific vaccine market revenue, by technology, 2014 2020 (USD
Million)
9.4.2. Asia Pacific vaccine market revenue, by type, 2014 2020 (USD Million)
9.4.3. Asia Pacific vaccine market revenue, by end user, 2014 2020 (USD
Million)
9.4.4. China
9.4.4.1. China vaccine market revenue, by technology, 2014 2020 (USD
Million)
sales@marketresearchstore.com

Vaccine Market
9.4.4.2. China vaccine market revenue, by type, 2014 2020 (USD
Million)
9.4.4.3. China vaccine market revenue, by end user, 2014 2020 (USD
Million)
9.4.5. Japan
9.4.5.1. Japan vaccine market revenue, by technology, 2014 2020 (USD
Million)
9.4.5.2. Japan vaccine market revenue, by type, 2014 2020 (USD
Million)
9.4.5.3. Japan vaccine market revenue, by end user, 2014 2020 (USD
Million)
9.4.6. India
9.4.6.1. India vaccine market revenue, by technology, 2014 2020 (USD
Million)
9.4.6.2. India vaccine market revenue, by type, 2014 2020 (USD Million)
9.4.6.3. India vaccine market revenue, by end user, 2014 2020 (USD
Million)
sales@marketresearchstore.com

Vaccine Market
9.5. Latin America
9.5.1. Latin America vaccine market revenue, by technology, 2014 2020 (USD
Million)
9.5.2. Latin America vaccine market revenue, by type, 2014 2020 (USD Million)
9.5.3. Latin America vaccine market revenue, by end user, 2014 2020 (USD
Million)
9.5.4. Brazil
9.5.4.1. Brazil vaccine market revenue, by technology, 2014 2020 (USD
Million)
9.5.4.2. Brazil vaccine market revenue, by type, 2014 2020 (USD
Million)
9.5.4.3. Brazil vaccine market revenue, by end user, 2014 2020 (USD
Million)
9.6. Middle East and Africa
9.6.1. Middle East and Africa vaccine market revenue, by technology, 2014 2020
(USD Million)

sales@marketresearchstore.com

Vaccine Market
9.6.2. Middle East and Africa vaccine market revenue, by type, 2014 2020 (USD
Million)
9.6.3. Middle East and Africa vaccine market revenue, by end user, 2014 2020
(USD Million)
Chapter 10. Company Profile
10.1. Pfizer
10.1.1. Overview
10.1.2. Financials
10.1.3. Product portfolio
10.1.4. Business strategy
10.1.5. Recent developments
10.2. CSL Limited
10.2.1. Overview
10.2.2. Financials
10.2.3. Product portfolio
10.2.4. Business strategy
10.2.5. Recent developments
sales@marketresearchstore.com

Vaccine Market
10.3. GlaxoSmithKline plc
10.3.1. Overview
10.3.2. Financials
10.3.3. Product portfolio
10.3.4. Business strategy
10.3.5. Recent developments
10.4. MedImmune LLC
10.4.1. Overview
10.4.2. Financials
10.4.3. Product portfolio
10.4.4. Business strategy
10.4.5. Recent developments
10.5. Novartis AG
10.5.1. Overview
10.5.2. Financials
10.5.3. Product portfolio
10.5.4. Business strategy
sales@marketresearchstore.com

Vaccine Market
10.5.5. Recent developments
10.6. Sanofi Pasteur
10.6.1. Overview
10.6.2. Financials
10.6.3. Product portfolio
10.6.4. Business strategy
10.6.5. Recent developments
10.7. Merck and Company
10.7.1. Overview
10.7.2. Financials
10.7.3. Product portfolio
10.7.4. Business strategy
10.7.5. Recent developments
10.8. Johnson and Johnson
10.8.1. Overview
10.8.2. Financials
10.8.3. Product portfolio
sales@marketresearchstore.com

Vaccine Market
10.8.4. Business strategy
10.8.5. Recent developments
10.9. Emergent BioSolutions Inc
10.9.1. Overview
10.9.2. Financials
10.9.3. Product portfolio
10.9.4. Business strategy
10.9.5. Recent developments
Browse the full "Vaccine Market by Technology (Inactivated, Subunit, Conjugate, Live Attenuated,
Toxoid, and Dendritic Cell Synthetic), Type (Therapeutic, Preventive), Indication (Allergy, Infectious
Disease, Tumors and Others) for Infants, Early Aged, and Post Aged: Global Industry Perspective,
Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2014 2020" report
at http://www.marketresearchstore.com/report/vaccine-market-z53045

Market Research Store

Address: Suite #8138, 3422 SW 15 Street, Deerfield Beach, Florida 33442, USA
Tel: +1-386-310-3803

Tel: +1-855-465-4651 (US/CAN TOLL FREE)

Email: sales@marketresearchstore.com

Web : http://www.marketresearchstore.com

sales@marketresearchstore.com